<div id="readability-page-1" class="page"><div> Novartis to Buy Biotech Excellergy for Up to $2 Billion Novartis agreed to buy Excellergy, bulking up its immunology portfolio with a biotech company that specializes in treatments for food allergy and other diseases. ---- China's Moonshot AI Seeks Listing in Hong Kong Under Heightened Scrutiny Moonshot AI, one of China's most promising artificial-intelligence startups, is considering changing its corporate structure to pave the way for an initial public offering in Hong Kong. ---- Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman The two companies are discussing a deal that is mostly stock and could be weeks away. ---- Jeep Cherokee Production Halted Over Supplier Dispute In a lawsuit, Stellantis said a payment dispute with a supplier has shut down a Mexican factory since March 14. ---- Anthropic Wins Injunction in Court Battle With Trump Administration A federal judge said the government's 'measures appear designed to punish Anthropic' in a standoff over military use of A.I. ---- The SpaceX IPO Will Be Just as Unconventional as Musk Himself From the investor meetings to how shares are doled out, Elon Musk is navigating his own path. ---- Orbital Data-Center Startup Aetherflux Raising New Financing at $2 Billion Valuation Aetherflux, led by Robinhood co-founder Baiju Bhatt, seeks to launch solar-powered satellites for AI computing. ---- An AI Upheaval Is Coming for Media. This Journalist Is Already All In. AI-assisted stories accounted for nearly 20% of Fortune's web traffic in the second half of 2025. Most are written by Nick Lichtenberg. ---- Netflix Raises Prices. Streaming Is Going to Keep Getting More Expensive. Netflix updated its plans page on Thursday. ---- FTC Issues Warnings to Payment Processors Against 'Debanking' Mastercard, Visa, PayPal and Stripe received letters warning them against denying customers access to financial services due to their political or religious views. ---- Why Tesla isn't getting a boost from high gas prices Higher EV prices and borrowing costs may be turning prospective buyers away. ---- GlobalFoundries Sues Tower Semiconductor for Patent Infringement The lawsuits allege that Tower infringed on 11 GlobalFoundries' patents in the U.S. ---- H&amp;M Earnings Rise as Cost Control Offsets Subdued Sales The fast-fashion retailer said sales picked up in February due to well-received spring collections, with the trend continuing into March. ---- Designer Brands Comparable Sales Fall Designer Brands reported lower comparable sales for the fiscal fourth quarter, dragged down by a decline in its direct-to-consumer channel. <pre></pre> (END) Dow Jones Newswires March 27, 2026 03:15 ET (07:15 GMT)Copyright (c) 2026 Dow Jones &amp; Company, Inc.</div></div>

诺华制药

伊克力西斯

LYEL

诺华计划以高达 20 亿美元收购 Excellergy，以增强其免疫学产品组合。与此同时，中国的 Moonshot AI 正在探索企业重组，以便在香港进行潜在的首次公开募股（IPO）。保乐力加正在与 Brown-Forman 进行合并谈判，而斯特兰蒂斯因供应商争议已暂停 Jeep Cherokee 的生产。Anthropic 赢得了一项针对特朗普政府关于军事人工智能使用的法院禁令。由 Robinhood 联合创始人领导的初创公司 Aetherflux 正在以 20 亿美元的估值筹集资金。奈飞已提高其价格，显示出流媒体成本上升的趋势

Dow Jones Top Company Headlines at 3 AM ET: Novartis to Buy Biotech Excellergy for Up to $2 Billion | China's ...

- 诺华同意以高达 20 亿美元收购生物技术公司 Excellergy。  
- 中国的 Moonshot AI 考虑变更公司结构，以便在香港上市。  
- 斯特兰提斯因与供应商的争端，自 3 月 14 日起停产 Jeep Cherokee。

MorningStar

Lyell Immunopharma

奈飞

Novartis AG

2 倍做多纳斯达克生物技术 ETF - ProShares

标普全球医疗股指数 ETF - iShares

医药突破 ETF - ALPS

标普生物技术 3 倍做多 - Direxion

基因改革 ETF - ARK

美国医药设备 ETF - iShares

医疗业 ETF - SPDR

Invesco Nasdaq Biotechnology ETF

标普生物技术 ETF - SPDR

纳斯达克生物科技指数 ETF - iShares Nasdaq

标普健康医疗设备 ETF - SPDR

2 倍做多 NFLX ETF - T-Rex

美国制药 ETF - iShares

纽交所高增长板生物技术指数 ETF - First Trust

医疗业 ETF - Vanguard

道琼斯公司头条新闻在凌晨 3 点：诺华制药计划以最高 20 亿美元收购生物技术公司 Excellergy | 中国的